Abstract |
In this investigation lymphocytes sensitized with Corynebacterium diphtheriae antigens obtained from carriers and convalescents were used. The new diphtheria bacterial vaccine Codivac, in contrast to other comparable preparations ( diphtheria toxoid, staphylococcal toxoid, staphylococcal vaccine, levamisole), was found to produce a more direct effect by modulating the levels of T-lymphocytes, depending on their initial levels in the patient. Codivac, together with other preparations, can be used for the study of the problems of immunostimulation and immunocorrective therapy.
|
Authors | S M Polkova, E A Shmeleva |
Journal | Zhurnal mikrobiologii, epidemiologii i immunobiologii
(Zh Mikrobiol Epidemiol Immunobiol)
Issue 12
Pg. 62-6
(Dec 1990)
ISSN: 0372-9311 [Print] Russia (Federation) |
Vernacular Title | Immunomoduliruiushchie svoĭstva difteriĭnoĭ bakterial'noĭ vaktsiny v opytakh in vitro. |
PMID | 2129148
(Publication Type: Comparative Study, English Abstract, Journal Article)
|
Chemical References |
- Adjuvants, Immunologic
- Antigens, Bacterial
- Codivac
- Diphtheria Toxoid
- Staphylococcal Toxoid
- Staphylococcal Vaccines
- Levamisole
|
Topics |
- Adjuvants, Immunologic
- Adolescent
- Adult
- Antigens, Bacterial
(immunology)
- Cells, Cultured
(drug effects, immunology)
- Corynebacterium diphtheriae
(immunology)
- Diphtheria Toxoid
(immunology, pharmacology)
- Drug Evaluation, Preclinical
- Humans
- Levamisole
(pharmacology)
- Middle Aged
- Staphylococcal Toxoid
(pharmacology)
- Staphylococcal Vaccines
(pharmacology)
- T-Lymphocytes
(drug effects, immunology)
|